listened to company's conference call today, they believe better than stalevo. 2 phase3 trials, 1 on advanced pd, other moderate pd, results in mid 2011. a better controlled release sinemet wouldn't hurt.
http://phx.corporate-ir.net/External...xUeXBlPTM=&t=1
pg. 21